WASHINGTON, Feb 26 (Reuters) – Drug manufacturer Hikma Pharmaceuticals Plc will sell the rights and assets of two generic drugs and relinquish its U.S. marketing rights to a third generic drug in…
The post U.S. sets conditions for Hikma’s takeover of Boehringer’s Roxane appeared first on NASDAQ.